Pharmafile Logo

Redmile

- PMLiVE

Duchenne UK backs Evox dystrophin delivery project

Funding will drive preclinical studies on dystrophin-bearing exosomes

- PMLiVE

Redmile and Google help Evox raise £35.5m for exosome pipeline

It is reported that GV contributed £10m of the total

- PMLiVE

Tony de Fougerolles joins Evox Therapeutics as CEO

He succeeds Dr Per Lundin who stays at the firm as COO

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links